8-14102421-C-G
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_139167.4(SGCZ):c.699G>C(p.Lys233Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000802 in 1,533,962 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.000066 ( 0 hom., cov: 30)
Exomes 𝑓: 0.000082 ( 0 hom. )
Consequence
SGCZ
NM_139167.4 missense
NM_139167.4 missense
Scores
10
6
Clinical Significance
Conservation
PhyloP100: 1.45
Genes affected
SGCZ (HGNC:14075): (sarcoglycan zeta) The zeta-sarcoglycan gene measures over 465 kb and localizes to 8p22. This protein is part of the sarcoglycan complex, a group of 6 proteins. The sarcoglycans are all N-glycosylated transmembrane proteins with a short intra-cellular domain, a single transmembrane region and a large extra-cellular domain containing a carboxyl-terminal cluster with several conserved cysteine residues. The sarcoglycan complex is part of the dystrophin-associated glycoprotein complex (DGC), which bridges the inner cytoskeleton and the extra-cellular matrix. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 2 ACMG points.
PM2
?
Very rare variant in population databases, with high coverage;
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SGCZ | NM_139167.4 | c.699G>C | p.Lys233Asn | missense_variant | 7/8 | ENST00000382080.6 | |
SGCZ | NM_001322879.2 | c.597G>C | p.Lys199Asn | missense_variant | 6/7 | ||
SGCZ | NM_001322880.2 | c.576G>C | p.Lys192Asn | missense_variant | 6/7 | ||
SGCZ | NM_001322881.2 | c.354G>C | p.Lys118Asn | missense_variant | 6/7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SGCZ | ENST00000382080.6 | c.699G>C | p.Lys233Asn | missense_variant | 7/8 | 5 | NM_139167.4 | P1 | |
SGCZ | ENST00000421524.6 | c.558G>C | p.Lys186Asn | missense_variant | 5/6 | 1 |
Frequencies
GnomAD3 genomes ? AF: 0.0000659 AC: 10AN: 151818Hom.: 0 Cov.: 30
GnomAD3 genomes
?
AF:
AC:
10
AN:
151818
Hom.:
Cov.:
30
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000108 AC: 25AN: 232486Hom.: 0 AF XY: 0.000119 AC XY: 15AN XY: 126242
GnomAD3 exomes
AF:
AC:
25
AN:
232486
Hom.:
AF XY:
AC XY:
15
AN XY:
126242
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000818 AC: 113AN: 1382028Hom.: 0 Cov.: 30 AF XY: 0.0000963 AC XY: 66AN XY: 685032
GnomAD4 exome
AF:
AC:
113
AN:
1382028
Hom.:
Cov.:
30
AF XY:
AC XY:
66
AN XY:
685032
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome ? AF: 0.0000658 AC: 10AN: 151934Hom.: 0 Cov.: 30 AF XY: 0.0000808 AC XY: 6AN XY: 74242
GnomAD4 genome
?
AF:
AC:
10
AN:
151934
Hom.:
Cov.:
30
AF XY:
AC XY:
6
AN XY:
74242
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
2
ExAC
?
AF:
AC:
11
Asia WGS
AF:
AC:
1
AN:
3478
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 16, 2022 | The c.699G>C (p.K233N) alteration is located in exon 7 (coding exon 7) of the SGCZ gene. This alteration results from a G to C substitution at nucleotide position 699, causing the lysine (K) at amino acid position 233 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
Cadd
Uncertain
Dann
Uncertain
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;D
M_CAP
Benign
D
MetaRNN
Uncertain
D;D
MetaSVM
Uncertain
D
MutationTaster
Benign
D;D
PrimateAI
Uncertain
T
PROVEAN
Benign
N;N
REVEL
Uncertain
Sift
Uncertain
D;D
Sift4G
Benign
T;T
Polyphen
P;D
Vest4
MutPred
0.47
.;Loss of ubiquitination at K186 (P = 0.027);
MVP
MPC
ClinPred
T
GERP RS
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at